Liquid human milk fortifier significantly improves docosahexaenoic and arachidonic acid status in preterm infants

C.L. Berseth, C.L. Harris, J.L. Wampler, D.R. Hoffman, D.A. Diersen-Schade
2014 Prostaglandins, Leukotrienes and Essential Fatty Acids  
We report the fatty acid composition of mother's own human milk from one of the largest US cohorts of lactating mothers of preterm infants. Milk fatty acid data were used as a proxy for intake at enrollment in infants (n ¼ 150) who received human milk with a powder human milk fortifier (HMF; Control) or liquid HMF [LHMF; provided additional 12 mg docosahexaenoic acid (DHA), 20 mg arachidonic acid (ARA)/ 100 mL human milk]. Mothers provided milk samples (n ¼ 129) and reported maternal DHA
more » ... tion (n ¼128). Infant blood samples were drawn at study completion (Study Day 28). Human milk and infant PPL fatty acids were analyzed using capillary column gas chromatography. DHA and ARA were within ranges previously published for US term and preterm human milk. Compared to Control HMF (providing no DHA or ARA), human milk fortified with LHMF significantly increased infant PPL DHA and ARA and improved preterm infant DHA and ARA status.
doi:10.1016/j.plefa.2014.03.002 pmid:24863250 fatcat:dvu5sdmypjcovf6q2pendoinni